홈 › 유방암 › 미시간 › Grand Rapids
MI Grand Rapids의 유방암 임상 시험
유방암 관련 연구 26개가 Grand Rapids 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- START - Midwest, Grand Rapids
A Study of PHST001 in Advanced Solid Tumors
피험자 모집 중1상
- START Center for Cancer Research - Midwest, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
피험자 모집 중
- Cancer & Hematology Centers, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
피험자 모집 중1상
- BAMF Health Inc., Grand Rapids
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
피험자 모집 중1상
- BAMF Health Inc., Grand Rapids
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
피험자 모집 중1/2상
- START Midwest, LLC, Grand Rapids
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- The Cancer & Hematology Centers, Grand Rapids
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- START - Midwest Cancer Research Center, Grand Rapids
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
피험자 모집 중3상
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
피험자 모집 중1상
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- START Midwest, Grand Rapids
E-Mindfulness Approaches for Living After Breast Cancer
피험자 모집 중3상
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
피험자 모집 중1/2상
- START Midwest, Grand Rapids
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
피험자 모집 중1상
- BAMF Health, Grand Rapids
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- START Midwest, LLC, Grand Rapids
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
피험자 모집 중2상
- GSK Investigational Site, Grand Rapids
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
피험자 모집 중3상
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
피험자 모집 중3상
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
피험자 모집 중관찰 연구
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
피험자 모집 중1/2상
- START, Midwest, Grand Rapids
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
피험자 모집 중1/2상
- START Midwest, Grand Rapids
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
피험자 모집 중3상
- Spectrum Health at Butterworth Campus, Grand Rapids
다른 도시의 유방암 시험
- New York City, NY연구 136개
- Houston, TX연구 126개
- Boston, MA연구 112개
- Nashville, TN연구 81개
- Los Angeles, CA연구 73개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Queens, NY연구 64개
- Durham, NC연구 64개
- Chicago, IL연구 59개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
Grand Rapids의 다른 연구
- 비소세포폐암연구 44개
- 대장직장암연구 40개
- 암 (전체)연구 28개
- 난소암연구 24개
- 전이성 암연구 22개
- 전립선암연구 19개
- 자궁내막암연구 18개
- 위암연구 18개
- 췌장암연구 18개
- 흑색종연구 17개
- 두경부 편평세포암연구 15개
- 삼중음성 유방암연구 15개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.